These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8254924)

  • 21. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
    Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathogenesis of pituitary tumours.
    Herman-Bonert V; Fagin JA
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):203-23. PubMed ID: 7625983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Classification and pathogenesis of pituitary adenomas in humans and animal experiments].
    Saeger W
    Fortschr Med; 1977 Jun; 95(22):1458-62. PubMed ID: 873431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
    Asa SL; Kelly MA; Grandy DK; Low MJ
    Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis.
    Boikos SA; Stratakis CA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R80-7. PubMed ID: 17613552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genesis of pituitary adenomas: state of the art.
    Faglia G; Spada A
    J Neurooncol; 2001 Sep; 54(2):95-110. PubMed ID: 11761437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives on the pathogenesis of clinically non-functioning pituitary tumours.
    Gittoes NJ
    J Endocrinol; 1998 May; 157(2):177-86. PubMed ID: 9659280
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
    Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
    Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and genetic characterization of FIPA (familial isolated pituitary adenomas)].
    Beckers A; Apetrii P; Daly A; Tichomirova M; Vanbellingen JF; Georges M; Bours V
    Rev Med Liege; 2009; 64 Spec No():15-9. PubMed ID: 20085010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis.
    Lloyd RV; Jin L; Chang A; Kulig E; Camper SA; Ross BD; Downs TR; Frohman LA
    Am J Pathol; 1992 Oct; 141(4):895-906. PubMed ID: 1415483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial pituitary tumors.
    Alband N; Korbonits M
    Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathology and pathogenesis of pituitary corticotroph adenoma].
    Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal signaling and pituitary adenomas.
    Spada A; Lania A; Mantovani G
    Neuroendocrinology; 2007; 85(2):101-9. PubMed ID: 17337884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
    Herman V; Drazin NZ; Gonsky R; Melmed S
    J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and pathogenesis of pituitary adenomas.
    Faglia G
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():1-5. PubMed ID: 8396832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.